Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07366892
What this trial is testing

Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use

Who this might be right for
Suspected Grade III and IV Gliomas Requiring Surgical InterventionNeurosurgical ProcedureGlioma+1 more
Leica Microsystems (Schweiz) AG 37
Not applicableStudy completedNCT01836536
What this trial is testing

Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients

Who this might be right for
GlioblastomaGlioma
Center Eugene Marquis 30
Testing effectiveness (Phase 2)Study completedNCT00612430
What this trial is testing

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Duke University 59
Early research (Phase 1)Study completedNCT00613132
What this trial is testing

Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Annick Desjardins 78
Early research (Phase 1)Looking for participantsNCT05460507
What this trial is testing

Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment

Who this might be right for
Glioma
Cerenome 40
Early research (Phase 1)Study completedNCT00004041
What this trial is testing

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Not applicableWithdrawnNCT04838782
What this trial is testing

Role of Repeat Resection in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma - Category
University of Alberta
Early research (Phase 1)WithdrawnNCT02055196
What this trial is testing

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00004024
What this trial is testing

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute 60
Early research (Phase 1)Study completedNCT00704080
What this trial is testing

XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

Who this might be right for
Mixed GliomasMalignant GliomasGlioblastoma Multiforme
Sanofi 54
Early research (Phase 1)Active Not RecruitingNCT04323046
What this trial is testing

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+3 more
Sabine Mueller, MD, PhD 9
Testing effectiveness (Phase 2)Study completedNCT00499473
What this trial is testing

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Diffuse AstrocytomaAdult Giant Cell Glioblastoma+5 more
National Cancer Institute (NCI) 31
Not applicableEnded earlyNCT02175745
What this trial is testing

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Who this might be right for
Adult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem Glioma+54 more
Erik Mittra 2
Testing effectiveness (Phase 2)Ended earlyNCT01778530
What this trial is testing

TRC105 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 2
Early research (Phase 1)Ended earlyNCT00671801
What this trial is testing

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

Who this might be right for
Malignant Gliomas
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00919737
What this trial is testing

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Nobelpharma 24
Early research (Phase 1)Active Not RecruitingNCT06894979
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Childhood AstrocytomaChildhood Diffuse Intrinsic Pontine GliomaChildhood Diffuse Midline Glioma+2 more
Children's Oncology Group 54
Early research (Phase 1)Ended earlyNCT04541225
What this trial is testing

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Who this might be right for
GliomaGlioma, MalignantGlioma, Mixed+21 more
Nuvation Bio Inc. 74
Testing effectiveness (Phase 2)Study completedNCT02661282
What this trial is testing

Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma

Who this might be right for
Cytomegalovirus PositiveGlioblastomaGliosarcoma+3 more
M.D. Anderson Cancer Center 65
Next Page